Identification of a polyoxometalate inhibitor of the DNA binding activity of sox2

Kamesh Narasimhan, Shubhadra Pillay, Nor Rizal Bin Ahmad, Zsolt Bikadi, Eszter Hazai, Li Yan, Prasanna Kolatkar, Konstantin Pervushin, Ralf Jauch

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Aberrant expression of transcription factors is a frequent cause of disease, yet drugs that modulate transcription factor protein-DNA interactions are presently unavailable. To this end, the chemical tractability of the DNA binding domain of the stem cell inducer and oncogene Sox2 was explored in a high-throughput fluorescence anisotropy screen. The screening revealed a Dawson polyoxometalate (K 6[P 2Mo 18O 62]) as a direct and nanomolar inhibitor of the DNA binding activity of Sox2. The Dawson polyoxometalate (Dawson-POM) was found to be selective for Sox2 and related Sox-HMG family members when compared to unrelated paired and zinc finger DNA binding domains. [ 15N, 1H]-Transverse relaxation optimized spectroscopy (TROSY) experiments coupled with docking studies suggest an interaction site of the POM on the Sox2 surface that enabled the rationalization of its inhibitory activity. The unconventional molecular scaffold of the Dawson-POM and its inhibitory mode provides strategies for the development of drugs that modulate transcription factors.

Original languageEnglish
Pages (from-to)573-581
Number of pages9
JournalACS Chemical Biology
Volume6
Issue number6
DOIs
Publication statusPublished - 17 Jun 2011
Externally publishedYes

Fingerprint

Transcription Factors
DNA
Fluorescence Polarization
Zinc Fingers
Stem cells
Oncogenes
Scaffolds
Pharmaceutical Preparations
Zinc
Spectrum Analysis
Screening
Anisotropy
Stem Cells
Fluorescence
Throughput
Spectroscopy
polyoxometalate I
Proteins
Experiments
Rationalization

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine

Cite this

Narasimhan, K., Pillay, S., Bin Ahmad, N. R., Bikadi, Z., Hazai, E., Yan, L., ... Jauch, R. (2011). Identification of a polyoxometalate inhibitor of the DNA binding activity of sox2. ACS Chemical Biology, 6(6), 573-581. https://doi.org/10.1021/cb100432x

Identification of a polyoxometalate inhibitor of the DNA binding activity of sox2. / Narasimhan, Kamesh; Pillay, Shubhadra; Bin Ahmad, Nor Rizal; Bikadi, Zsolt; Hazai, Eszter; Yan, Li; Kolatkar, Prasanna; Pervushin, Konstantin; Jauch, Ralf.

In: ACS Chemical Biology, Vol. 6, No. 6, 17.06.2011, p. 573-581.

Research output: Contribution to journalArticle

Narasimhan, K, Pillay, S, Bin Ahmad, NR, Bikadi, Z, Hazai, E, Yan, L, Kolatkar, P, Pervushin, K & Jauch, R 2011, 'Identification of a polyoxometalate inhibitor of the DNA binding activity of sox2', ACS Chemical Biology, vol. 6, no. 6, pp. 573-581. https://doi.org/10.1021/cb100432x
Narasimhan K, Pillay S, Bin Ahmad NR, Bikadi Z, Hazai E, Yan L et al. Identification of a polyoxometalate inhibitor of the DNA binding activity of sox2. ACS Chemical Biology. 2011 Jun 17;6(6):573-581. https://doi.org/10.1021/cb100432x
Narasimhan, Kamesh ; Pillay, Shubhadra ; Bin Ahmad, Nor Rizal ; Bikadi, Zsolt ; Hazai, Eszter ; Yan, Li ; Kolatkar, Prasanna ; Pervushin, Konstantin ; Jauch, Ralf. / Identification of a polyoxometalate inhibitor of the DNA binding activity of sox2. In: ACS Chemical Biology. 2011 ; Vol. 6, No. 6. pp. 573-581.
@article{668ad6b6f8934229a72aac810742f564,
title = "Identification of a polyoxometalate inhibitor of the DNA binding activity of sox2",
abstract = "Aberrant expression of transcription factors is a frequent cause of disease, yet drugs that modulate transcription factor protein-DNA interactions are presently unavailable. To this end, the chemical tractability of the DNA binding domain of the stem cell inducer and oncogene Sox2 was explored in a high-throughput fluorescence anisotropy screen. The screening revealed a Dawson polyoxometalate (K 6[P 2Mo 18O 62]) as a direct and nanomolar inhibitor of the DNA binding activity of Sox2. The Dawson polyoxometalate (Dawson-POM) was found to be selective for Sox2 and related Sox-HMG family members when compared to unrelated paired and zinc finger DNA binding domains. [ 15N, 1H]-Transverse relaxation optimized spectroscopy (TROSY) experiments coupled with docking studies suggest an interaction site of the POM on the Sox2 surface that enabled the rationalization of its inhibitory activity. The unconventional molecular scaffold of the Dawson-POM and its inhibitory mode provides strategies for the development of drugs that modulate transcription factors.",
author = "Kamesh Narasimhan and Shubhadra Pillay and {Bin Ahmad}, {Nor Rizal} and Zsolt Bikadi and Eszter Hazai and Li Yan and Prasanna Kolatkar and Konstantin Pervushin and Ralf Jauch",
year = "2011",
month = "6",
day = "17",
doi = "10.1021/cb100432x",
language = "English",
volume = "6",
pages = "573--581",
journal = "ACS Chemical Biology",
issn = "1554-8929",
publisher = "American Chemical Society",
number = "6",

}

TY - JOUR

T1 - Identification of a polyoxometalate inhibitor of the DNA binding activity of sox2

AU - Narasimhan, Kamesh

AU - Pillay, Shubhadra

AU - Bin Ahmad, Nor Rizal

AU - Bikadi, Zsolt

AU - Hazai, Eszter

AU - Yan, Li

AU - Kolatkar, Prasanna

AU - Pervushin, Konstantin

AU - Jauch, Ralf

PY - 2011/6/17

Y1 - 2011/6/17

N2 - Aberrant expression of transcription factors is a frequent cause of disease, yet drugs that modulate transcription factor protein-DNA interactions are presently unavailable. To this end, the chemical tractability of the DNA binding domain of the stem cell inducer and oncogene Sox2 was explored in a high-throughput fluorescence anisotropy screen. The screening revealed a Dawson polyoxometalate (K 6[P 2Mo 18O 62]) as a direct and nanomolar inhibitor of the DNA binding activity of Sox2. The Dawson polyoxometalate (Dawson-POM) was found to be selective for Sox2 and related Sox-HMG family members when compared to unrelated paired and zinc finger DNA binding domains. [ 15N, 1H]-Transverse relaxation optimized spectroscopy (TROSY) experiments coupled with docking studies suggest an interaction site of the POM on the Sox2 surface that enabled the rationalization of its inhibitory activity. The unconventional molecular scaffold of the Dawson-POM and its inhibitory mode provides strategies for the development of drugs that modulate transcription factors.

AB - Aberrant expression of transcription factors is a frequent cause of disease, yet drugs that modulate transcription factor protein-DNA interactions are presently unavailable. To this end, the chemical tractability of the DNA binding domain of the stem cell inducer and oncogene Sox2 was explored in a high-throughput fluorescence anisotropy screen. The screening revealed a Dawson polyoxometalate (K 6[P 2Mo 18O 62]) as a direct and nanomolar inhibitor of the DNA binding activity of Sox2. The Dawson polyoxometalate (Dawson-POM) was found to be selective for Sox2 and related Sox-HMG family members when compared to unrelated paired and zinc finger DNA binding domains. [ 15N, 1H]-Transverse relaxation optimized spectroscopy (TROSY) experiments coupled with docking studies suggest an interaction site of the POM on the Sox2 surface that enabled the rationalization of its inhibitory activity. The unconventional molecular scaffold of the Dawson-POM and its inhibitory mode provides strategies for the development of drugs that modulate transcription factors.

UR - http://www.scopus.com/inward/record.url?scp=79961094533&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79961094533&partnerID=8YFLogxK

U2 - 10.1021/cb100432x

DO - 10.1021/cb100432x

M3 - Article

VL - 6

SP - 573

EP - 581

JO - ACS Chemical Biology

JF - ACS Chemical Biology

SN - 1554-8929

IS - 6

ER -